[Effect of cilazapril and valsartan on the levels of cardiac interstitial water content in rats with acute myocardial infarction].
Sun
Jing
J
Tianjin Chest Hospital, Tianjin, China.
Zhang
Shi-Shu
SS
Mao
Yong-Min
YM
Sun
Gen-Yi
GY
Zhao
Hong-Ming
HM
Liu
Guo-Qing
GQ
Cui
Rang-Zhuang
RZ
D000818:Animals; D000959:Antihypertensive Agents / Q000627:therapeutic use; D017315:Cilazapril / Q000627:therapeutic use*; D004195:Disease Models, Animal; D008297:Male; D020778:Matrix Metalloproteinase 2 / Q000378:metabolism; D009203:Myocardial Infarction / Q000188:drug therapy / Q000378:metabolism*; D009206:Myocardium / Q000378:metabolism*; D012333:RNA, Messenger / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar; D044140:Receptor, Angiotensin, Type 1 / Q000378:metabolism; D044139:Receptor, Angiotensin, Type 2 / Q000378:metabolism; D013777:Tetrazoles / Q000627:therapeutic use*; D019715:Tissue Inhibitor of Metalloproteinase-1 / Q000378:metabolism; D014633:Valine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000068756:Valsartan
D000959:Antihypertensive Agents; D012333:RNA, Messenger; D044140:Receptor, Angiotensin, Type 1; D044139:Receptor, Angiotensin, Type 2; D013777:Tetrazoles; D019715:Tissue Inhibitor of Metalloproteinase-1; D017315:Cilazapril; D000068756:Valsartan; D020778:Matrix Metalloproteinase 2; D014633:Valine